Published in Blood on October 15, 2014
Tumor-suppressor genes that escape from X-inactivation contribute to cancer sex bias. Nat Genet (2016) 1.57
An integrative view on sex differences in brain tumors. Cell Mol Life Sci (2015) 1.04
Derivation of consensus inactivation status for X-linked genes from genome-wide studies. Biol Sex Differ (2015) 1.00
The genetics and mechanisms of T cell acute lymphoblastic leukaemia. Nat Rev Cancer (2016) 1.00
Targeted sequencing identifies associations between IL7R-JAK mutations and epigenetic modulators in T-cell acute lymphoblastic leukemia. Haematologica (2015) 0.96
Histone H3 Lysine 27 demethylases Jmjd3 and Utx are required for T-cell differentiation. Nat Commun (2015) 0.96
Targeting EZH2 and PRC2 dependence as novel anticancer therapy. Exp Hematol (2015) 0.95
UTX inhibits EMT-induced breast CSC properties by epigenetic repression of EMT genes in cooperation with LSD1 and HDAC1. EMBO Rep (2015) 0.85
UTX inhibition as selective epigenetic therapy against TAL1-driven T-cell acute lymphoblastic leukemia. Genes Dev (2016) 0.83
When the Lyon(ized chromosome) roars: ongoing expression from an inactive X chromosome. Philos Trans R Soc Lond B Biol Sci (2017) 0.81
Histone demethylases in physiology and cancer: a tale of two enzymes, JMJD3 and UTX. Curr Opin Genet Dev (2016) 0.81
Genomic characterization of pediatric T-cell acute lymphoblastic leukemia reveals novel recurrent driver mutations. Oncotarget (2016) 0.79
Emerging concepts of epigenetic dysregulation in hematological malignancies. Nat Immunol (2016) 0.79
The genetics and molecular biology of T-ALL. Blood (2017) 0.78
Childhood acute lymphoblastic leukemia: Integrating genomics into therapy. Cancer (2015) 0.78
Sexual dimorphism in cancer. Nat Rev Cancer (2016) 0.78
H3K27 Methylation: A Focal Point of Epigenetic Deregulation in Cancer. Adv Cancer Res (2016) 0.78
Comprehensive Characterization of Molecular Differences in Cancer between Male and Female Patients. Cancer Cell (2016) 0.77
Y-chromosomal genes affecting male fertility: A review. Vet World (2016) 0.77
X-chromosome inactivation and escape. J Genet (2015) 0.76
The complexity of epigenetic diseases. J Pathol (2015) 0.76
Lysine-specific histone demethylases in normal and malignant hematopoiesis. Exp Hematol (2016) 0.76
An X-linked tumor suppressor in T-ALL. Blood (2015) 0.76
Marked for death: targeting epigenetic changes in cancer. Nat Rev Drug Discov (2017) 0.76
Pleiotropic Functions of H3K27Me3 Demethylases in Immune Cell Differentiation. Trends Immunol (2016) 0.76
The genomic landscape of pediatric and young adult T-lineage acute lymphoblastic leukemia. Nat Genet (2017) 0.75
Genomic characterization of paediatric acute lymphoblastic leukaemia: an opportunity for precision medicine therapeutics. Br J Haematol (2016) 0.75
The Role of Histone Protein Modifications and Mutations in Histone Modifiers in Pediatric B-Cell Progenitor Acute Lymphoblastic Leukemia. Cancers (Basel) (2017) 0.75
Epigenetic Dysfunction in Turner Syndrome Immune Cells. Curr Allergy Asthma Rep (2016) 0.75
RBP2 Promotes Adult Acute Lymphoblastic Leukemia by Upregulating BCL2. PLoS One (2016) 0.75
Histone Demethylase KDM6A Controls the Mammary Luminal Lineage through Enzyme-Independent Mechanisms. Mol Cell Biol (2016) 0.75
Non-negligible Occurrence of Errors in Gender Description in Public Data Sets. Genomics Inform (2016) 0.75
Context Specific and Differential Gene Co-expression Networks via Bayesian Biclustering. PLoS Comput Biol (2016) 0.75
Epigenetics in Normal and Malignant Hematopoiesis: An Overview and Update 2017. Cancer Sci (2017) 0.75
Heterochromatin Reduction Correlates with the Increase of the KDM4B and KDM6A Demethylases and the Expression of Pericentromeric DNA during the Acquisition of a Transformed Phenotype. J Cancer (2017) 0.75
Aberrant Signaling Pathways in T-Cell Acute Lymphoblastic Leukemia. Int J Mol Sci (2017) 0.75
The Histone H3K27 Demethylase UTX Regulates Synaptic Plasticity and Cognitive Behaviors in Mice. Front Mol Neurosci (2017) 0.75
Differential Effects of Histone Acetyltransferase GCN5 or PCAF Knockdown on Urothelial Carcinoma Cells. Int J Mol Sci (2017) 0.75
Leukemia-Initiating Cells in T-Cell Acute Lymphoblastic Leukemia. Front Oncol (2017) 0.75
Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A (2005) 167.46
Role of histone H3 lysine 27 methylation in Polycomb-group silencing. Science (2002) 24.31
Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia. Science (2004) 18.84
Somatic mutations altering EZH2 (Tyr641) in follicular and diffuse large B-cell lymphomas of germinal-center origin. Nat Genet (2010) 10.97
Somatic mutations of the histone H3K27 demethylase gene UTX in human cancer. Nat Genet (2009) 10.21
The genetic basis of early T-cell precursor acute lymphoblastic leukaemia. Nature (2012) 9.89
UTX and JMJD3 are histone H3K27 demethylases involved in HOX gene regulation and development. Nature (2007) 8.32
Pharmacologic disruption of Polycomb-repressive complex 2-mediated gene repression selectively induces apoptosis in cancer cells. Genes Dev (2007) 6.71
Gene expression signatures define novel oncogenic pathways in T cell acute lymphoblastic leukemia. Cancer Cell (2002) 6.64
A histone H3 lysine 27 demethylase regulates animal posterior development. Nature (2007) 6.57
Frequent mutations of chromatin remodeling genes in transitional cell carcinoma of the bladder. Nat Genet (2011) 5.73
Novel mutations target distinct subgroups of medulloblastoma. Nature (2012) 4.82
Exclusive development of T cell neoplasms in mice transplanted with bone marrow expressing activated Notch alleles. J Exp Med (1996) 4.79
FBW7 mutations in leukemic cells mediate NOTCH pathway activation and resistance to gamma-secretase inhibitors. J Exp Med (2007) 4.59
The SCFFBW7 ubiquitin ligase complex as a tumor suppressor in T cell leukemia. J Exp Med (2007) 4.04
EZH2 is required for germinal center formation and somatic EZH2 mutations promote lymphoid transformation. Cancer Cell (2013) 3.13
HOXA genes are included in genetic and biologic networks defining human acute T-cell leukemia (T-ALL). Blood (2005) 3.09
The molecular basis of T cell acute lymphoblastic leukemia. J Clin Invest (2012) 3.09
The UTX gene escapes X inactivation in mice and humans. Hum Mol Genet (1998) 2.91
Integrated transcript and genome analyses reveal NKX2-1 and MEF2C as potential oncogenes in T cell acute lymphoblastic leukemia. Cancer Cell (2011) 2.89
Childhood T-cell acute lymphoblastic leukemia: the Dana-Farber Cancer Institute acute lymphoblastic leukemia consortium experience. J Clin Oncol (2003) 2.88
Genetic inactivation of the polycomb repressive complex 2 in T cell acute lymphoblastic leukemia. Nat Med (2012) 2.86
PHF6 mutations in T-cell acute lymphoblastic leukemia. Nat Genet (2010) 2.66
Exome sequencing identifies mutation in CNOT3 and ribosomal genes RPL5 and RPL10 in T-cell acute lymphoblastic leukemia. Nat Genet (2012) 2.64
Clonal selection in xenografted human T cell acute lymphoblastic leukemia recapitulates gain of malignancy at relapse. J Exp Med (2011) 2.04
A cooperative microRNA-tumor suppressor gene network in acute T-cell lymphoblastic leukemia (T-ALL). Nat Genet (2011) 1.99
DOCK4, a GTPase activator, is disrupted during tumorigenesis. Cell (2003) 1.94
A key role for EZH2 and associated genes in mouse and human adult T-cell acute leukemia. Genes Dev (2012) 1.75
arrayCGHbase: an analysis platform for comparative genomic hybridization microarrays. BMC Bioinformatics (2005) 1.71
mel-18, a Polycomb group-related mammalian gene, encodes a transcriptional negative regulator with tumor suppressive activity. EMBO J (1995) 1.54
Aberrant CpG island methylation in acute myeloid leukemia is accentuated at relapse. Blood (2008) 1.52
Leukemia-associated NF1 inactivation in patients with pediatric T-ALL and AML lacking evidence for neurofibromatosis. Blood (2008) 1.51
Frequent mutation of the major cartilage collagen gene COL2A1 in chondrosarcoma. Nat Genet (2013) 1.45
Sex-specific differences in expression of histone demethylases Utx and Uty in mouse brain and neurons. J Neurosci (2008) 1.42
Coding sequences of the tal-1 gene are disrupted by chromosome translocation in human T cell leukemia. J Exp Med (1990) 1.39
KDM6A point mutations cause Kabuki syndrome. Hum Mutat (2012) 1.35
Gene expression profiles during human CD4+ T cell differentiation. Int Immunol (2004) 1.27
MOHITO, a novel mouse cytokine-dependent T-cell line, enables studies of oncogenic signaling in the T-cell context. Haematologica (2010) 1.16
Deletions of PURA, at 5q31, and PURB, at 7p13, in myelodysplastic syndrome and progression to acute myelogenous leukemia. Leukemia (2001) 0.98
The H3K27me3 demethylase UTX in normal development and disease. Epigenetics (2014) 0.97
Female bias in Rhox6 and 9 regulation by the histone demethylase KDM6A. PLoS Genet (2013) 0.91
Deletion of leucine zipper tumor suppressor 2 (Lzts2) increases susceptibility to tumor development. J Biol Chem (2012) 0.86
LIN28B overexpression defines a novel fetal-like subgroup of juvenile myelomonocytic leukemia. Blood (2015) 0.81
Contribution of the Ly49E natural killer receptor in the immune response to Plasmodium berghei infection and control of hepatic parasite development. PLoS One (2014) 0.79
Human T cell development notched up a level. Nat Methods (2017) 0.75
Persistent rotavirus diarrhea post-transplant in a novel JAK3-SCID patient after vaccination. Pediatr Allergy Immunol (2015) 0.75